Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Energy metabolism and aging pathways in human stem cell reprogramming and differentiation

  • Post author:
  • Post published:December 20, 2025
  • Post category:

The discovery that human skin cells can be reprogrammed into stem cells holds great promise for therapies for degenerative diseases. As many patients in need of regenerative medicine therapies are…

Continue ReadingEnergy metabolism and aging pathways in human stem cell reprogramming and differentiation

Stem cell models to analyze the role of mutated C9ORF72 in neurodegeneration

  • Post author:
  • Post published:December 20, 2025
  • Post category:

Amyotrophic lateral sclerosis (ALS) is an idiopathic adult-onset degenerative disease characterized by progressive weakness from loss of upper and lower motor neurons. Onset is insidious, progression is essentially linear, and…

Continue ReadingStem cell models to analyze the role of mutated C9ORF72 in neurodegeneration

The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development

  • Post author:
  • Post published:December 20, 2025
  • Post category:

Continue ReadingThe HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development

Identifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells

  • Post author:
  • Post published:December 20, 2025
  • Post category:

We propose to discover new drug candidates for Alzheimer’s Disease (AD), which is common, fatal, and for which no effective disease-modifying drugs are available. Because no effective AD treatment is…

Continue ReadingIdentifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells

Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease

  • Post author:
  • Post published:December 20, 2025
  • Post category:

Autophagy is the cells mechanism for breaking down and recycling proteins. Danon disease is an inherited disorder of autophagy. Patients with this disease have major abnormalities in heart and skeletal…

Continue ReadingIdentification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease

Autologous iPSC Therapy for Urinary Incontinence

  • Post author:
  • Post published:December 20, 2025
  • Post category:

Urinary incontinence (UI) is common and serious, with two-thirds of the burden borne by women. UI impacts both quality and length of life; women with UI suffer debilitating falls, experience…

Continue ReadingAutologous iPSC Therapy for Urinary Incontinence

Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells

  • Post author:
  • Post published:December 20, 2025
  • Post category:

Multiple Sclerosis (MS) is a disease of the central nervous system (CNS) caused by inflammation and loss of cells that produce myelin, which normally insulates and protects nerve cells. MS…

Continue ReadingMultiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells

Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons

  • Post author:
  • Post published:December 20, 2025
  • Post category:

Approximately 5,600 people in the U.S. are diagnosed with ALS each year. The incidence of ALS is two per 100,000 people, and it is estimated that as many as 30,000…

Continue ReadingMolecules to Correct Aberrant RNA Signature in Human Diseased Neurons

Use of human iPS cells to study spinal muscular atrophy

  • Post author:
  • Post published:December 20, 2025
  • Post category:

Spinal muscular atrophy (SMA) is one of the most common autosomal recessive disorders that cause infant mortality. SMA is caused by loss of the Survival of Motor Neuron (SMN) protein,…

Continue ReadingUse of human iPS cells to study spinal muscular atrophy

Correlated time-lapse imaging and single cell molecular analysis of human embryo development

  • Post author:
  • Post published:December 20, 2025
  • Post category:

We understand little about human development especially at the earliest stages. Yet human developmental biology is very important to stem cell biology and regenerative medicine for two reasons: 1) Understanding…

Continue ReadingCorrelated time-lapse imaging and single cell molecular analysis of human embryo development
  • Go to the previous page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 34
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us